Home
Browse All Titles
Sign In
Browse All Titles
CURRENT Practice Guidelines In Primary Care
About
Table of Contents
Main Index
Image Index
Table Index
Flowchart Index
Calculator Index
Medication Index
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com:11002
◀
T
▶
View All
Table 13-1 Clinical Recommendations For Use of Professionally Applied or Prescription-Strength, Home-Use Topical Fluoride Agents For Caries Prevention in Patients At Elevated Risk of Developing Caries
Table 13-3 Cutoffs For Pediatric Stage 1 Hypertension
Table 19-10 Impact of Health Behavior Management On Blood Pressure
Table 19-12 Screening BP Values Requiring Further Evaluation
Table 19-2 Rate Control in Atrial Fibrillation: Calcium Channel Blockers
Table 19-4 Rate Control in Atrial Fibrillation: Antiarrhythmics
Table 19-6 Has-Bled Bleeding Risk Score For Warfarin Therapy
Table 19-8 Comparing Warfarin with Doacs
Table 1 Recommended Child and Adolescent Immunization Schedule For Ages 18 Y or Younger, United States, 2023
Table 2-10 Caprini Risk Stratification Model
Table 21-2 Recommendations For Adjunctive Diabetes Therapies Complementary to Common Comorbidities
Table 10-1 Stages of Acute Kidney Injury
Table 13-2 Recommended Fluoride Supplementation by Age and Fluoride Level in Community Water Supply
Table 15-1 Cervical Cancer Screening Recommendations
Table 19-11 Lifestyle Modifications For Treatment of Hypertension
Table 19-1 Rate Control in Atrial Fibrillation: Beta-Blockers
Table 19-3 Rate Control in Atrial Fibrillation: Cardiac Glycosides
Table 19-5 Stroke Risk Stratification with the Chads2 and Cha2ds2-Vasc Scores
Table 19-7 Thromboembolic Risk Scores in Nonvalvular Atrial Fibrillation
Table 19-9 Diabetes Medications with Cardiovascular Benefits
Table 20-1 Palliative and End-of-Life Care: Pain Management.
Table 21-1 Dosing and Monitoring of Antithyroid Drug Therapy
Table 21-3 International Panel Guideline On Selecting Sglt-2 Inhibitors or Glp-1 Receptor Agonists
Table 22-1 Acute Otitis Media—approaches to Treatment
Table 2-2 Statin Intensity Drug Levels
Table 2-3 Statin-Associated Side Effects
Table 24-2 Responses to Abnormal Screening Results, Patients Age 25-65 with Prior Anomaliesa
Table 24-4 Risk-Stratified Evaluation of Microscopic Hematuria
Table 24-6 Clinical Diagnosis of Vaginitis
Table 25-11 Selected Second-Line Therapy Options in Adult ITP
Refresh
first
prev
1
2
3
30
select
next
last
Displaying items 1 - 30 of 73